Published by Iain Gilbert on 22nd April 2025
(Sharecast News) - Pharmacitucal firm Shield Therapeutics said on Tuesday that it had inked an exclusive licence agreement for its ACCRUFeR iron deficiency asset in Japan with VITAL-NET.
URL: http://www.digitallook.com/dl/news/story/35025631/...